Your browser doesn't support javascript.
loading
In vivo flow cytometry reveals an anti-metastatic effect of Rujifang in triple-negative breast cancer.
Zhang, Fuli; Li, Hongliang; Lin, Xuan; Zhu, Xi; Chen, Xuezhang; Wang, Bin; Zhu, Zhixia; Chen, Xikang; Liang, Guiwen; Zhang, Jingtao; Wei, Xunbin; Tian, Huaqin.
Afiliação
  • Zhang F; Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Li H; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Lin X; Cancer Center, The 8th Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
  • Zhu X; School of Rehabilitation, Kunming Medical University, Kunming, China.
  • Chen X; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Wang B; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Zhu Z; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Chen X; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Liang G; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Zhang J; Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Wei X; Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Tian H; Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
Cytometry A ; 103(9): 723-731, 2023 09.
Article em En | MEDLINE | ID: mdl-37276218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2023 Tipo de documento: Article